Destiny Pharma plc
DEST.L · LSE
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | £67 | £23 | £39 | £27 |
| - Cash | £6 | £10 | £5 | £8 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £60 | £13 | £34 | £19 |
| Revenue | £0 | £1 | £0 | £0 |
| % Growth | -100% | 438.2% | – | – |
| Gross Profit | -£0 | £1 | £0 | -£0 |
| % Margin | – | 99.6% | 96.1% | – |
| EBITDA | -£3 | -£3 | -£4 | -£4 |
| % Margin | – | -389.5% | -2,652.5% | – |
| Net Income | -£3 | -£3 | -£3 | -£3 |
| % Margin | – | -319.8% | -2,145.8% | – |
| EPS Diluted | -0.032 | -0.031 | -0.045 | -0.048 |
| % Growth | -1.9% | 31.6% | 5.6% | – |
| Operating Cash Flow | -£4 | -£2 | -£4 | -£2 |
| Capital Expenditures | -£0 | -£0 | -£0 | £0 |
| Free Cash Flow | -£4 | -£2 | -£4 | -£2 |